Search
for
Sort by
Research 181–210 of 211
- Revolutionizing psoriasis care: Microneedle innovations in treatment and diagnosis
- Causal Link of Distinct Mental Disorders with Androgenetic Alopecia and Alopecia Areata: A Bidirectional Two-Sample Mendelian Randomization Study
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Recent Advances in Drug Development for Hair Loss
- Metabolic pathways of eicosanoids—derivatives of arachidonic acid and their significance in skin
- Understanding the Intricate Pathophysiology of Psoriasis and Related Skin Disorders
- Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
- Unveiling the Effect of Age and IgE Level on Alopecia Areata: Insights from Comparative RNAseq Analysis
- The Role of Linoleic Acid in Skin and Hair Health: A Review
- An Integrated Approach to Develop Innovative, Sustainable, and Effective Cosmetic Ingredients: The Case Report of Fatty-Acids-Enriched Wild Strawberry Waste Extract
- Mesenchymal Stem Cell Therapy in Alopecia Areata: Visual and Molecular Evidence from a Mouse Model
- Alopecia areata exhibits cutaneous and systemic OX40 activation across atopic backgrounds
- Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children
- Features of sensitization in patients with alopecia areata, associated with atopic diseases
- Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- Tracing immune cells around biomaterials with spatial anchors during large-scale wound regeneration
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- New Treatment Options for Alopecia Areata
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- Combination of topical anthralin and calcipotriene in alopecia areata: A discussion of the mechanisms of action
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- Quoi de neuf en dermatologie pédiatrique ?
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Interdisciplinarity traditional Chinese medicine microneedles in skin disease treatment: Recent advances and challenges
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- New developments in the molecular treatment of ichthyosis: review of the literature
- The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds